Year archive

Evogene Ltd. — 2024 filings

All 175 regulatory filings released by Evogene Ltd. (EVGN) in 2024, sourced directly from the official regulator.

175 Filings

2024 Period

2024 filings (175)

Filing	Released	Lang
NOTICE OF SPECIAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 5, 2025 AGM Information	2024-12-30	English
NOTICE OF SPECIAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 5, 2025 AGM Information	2024-12-30	English
NOTICE OF SPECIAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 5, 2025 AGM Information	2024-12-30	English
6-K Foreign Filer Report	2024-12-30	English
PROSPECTUS SUPPLEMENT NO. 2 Regulatory Filings	2024-11-28	English
PROSPECTUS SUPPLEMENT NO. 2 Report Publication Announcement	2024-11-28	English
Lavie Bio received a notice of termination from Corteva of the licensing agreement dated July 14, 2023 Regulatory Filings	2024-11-27	English
Lavie Bio received a notice of termination from Corteva of the licensing agreement dated July 14, 2023 Report Publication Announcement	2024-11-27	English
424B3 Prospectus	2024-11-27	English
6-K Foreign Filer Report	2024-11-27	English
Amendment #1 to Prospectus Supplement Interim / Quarterly Report 9M 2024	2024-11-21	English
Amendment #1 to Prospectus Supplement Report Publication Announcement	2024-11-21	English
Reports Third Quarter 2024 Financial Results Earnings Release Q3 2024	2024-11-21	English
Reports Third Quarter 2024 Financial Results Report Publication Announcement	2024-11-21	English
424B3 Prospectus	2024-11-21	English
6-K Foreign Filer Report	2024-11-21	English
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results Regulatory Filings	2024-11-19	English
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results Report Publication Announcement	2024-11-19	English
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials Regulatory Filings	2024-11-12	English
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials Report Publication Announcement	2024-11-12	English
It will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024, a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). Report Publication Announcement	2024-11-07	English
It will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024, a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). Report Publication Announcement	2024-11-07	English
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design Regulatory Filings	2024-10-31	English
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design Report Publication Announcement	2024-10-31	English
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya Regulatory Filings	2024-10-29	English
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya Report Publication Announcement	2024-10-29	English
SC 13G/A Major Shareholding Notification	2024-10-15	English
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology (duplicate Regulatory Filings	2024-10-08	English
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology (duplicate Report Publication Announcement	2024-10-08	English
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology Regulatory Filings	2024-10-08	English
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology Report Publication Announcement	2024-10-08	English
PROSPECTUS Share Issue/Capital Change	2024-10-01	English
PROSPECTUS Report Publication Announcement	2024-10-01	English
424B3 Prospectus	2024-09-30	English
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals Regulatory Filings	2024-09-30	English
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals Report Publication Announcement	2024-09-30	English
Regulatory Filings 2024 Regulatory Filings	2024-09-30	English
Regulatory Filings 2024 Regulatory Filings	2024-09-25	English
Regulatory Filings 2024 Regulatory Filings	2024-09-24	English
FORM F-1-REGISTRATION STATEMENT Regulatory Filings	2024-09-20	English
FORM F-1-REGISTRATION STATEMENT Report Publication Announcement	2024-09-20	English
F-1 Regulatory Filings	2024-09-19	English
Changes in Management Board/Management Information	2024-09-17	English
Changes in Management Board/Management Information	2024-09-17	English
6-K Foreign Filer Report	2024-09-17	English
Operating and Financial Review and Prospects as of, and for the six month ended, June 30, 2024 Interim / Quarterly Report H1 2024	2024-09-17	English
Operating and Financial Review and Prospects as of, and for the six month ended, June 30, 2024 Report Publication Announcement	2024-09-17	English
6-K Foreign Filer Report	2024-09-16	English
Regulatory Filings 2024 Regulatory Filings	2024-09-04	English
Prospectus Supplement Capital/Financing Update	2024-08-26	English
Prospectus Supplement Capital/Financing Update	2024-08-26	English
424B5 Prospectus	2024-08-26	English
Prospectus Supplement No. 1-Accessible version Capital/Financing Update	2024-08-26	English
Prospectus Supplement No. 1-Accessible version Report Publication Announcement	2024-08-26	English
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement-Accessible version Regulatory Filings	2024-08-26	English
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement-Accessible version Report Publication Announcement	2024-08-26	English
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement Regulatory Filings	2024-08-23	English
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement Report Publication Announcement	2024-08-23	English
6-K Foreign Filer Report	2024-08-23	English
Prospectus Supplement No. 1 Capital/Financing Update	2024-08-23	English
Prospectus Supplement No. 1 Report Publication Announcement	2024-08-23	English
424B5 Prospectus	2024-08-23	English
Evogene Reports Second Quarter 2024 Financial Results Earnings Release Q2 2024	2024-08-22	English
Evogene Reports Second Quarter 2024 Financial Results Report Publication Announcement	2024-08-22	English
6-K Foreign Filer Report	2024-08-22	English
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule Regulatory Filings	2024-08-12	English
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule Report Publication Announcement	2024-08-12	English
schedules Second Quarter 2024 Financial Results Release on August 22, 2024,conference call to discuss the results at 4:00 PM Israel time Report Publication Announcement	2024-08-12	English
schedules Second Quarter 2024 Financial Results Release on August 22, 2024,conference call to discuss the results at 4:00 PM Israel time Report Publication Announcement	2024-08-12	English
6-K Foreign Filer Report	2024-08-12	English
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil Earnings Release Q3 2024	2024-07-31	English
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil Report Publication Announcement	2024-07-31	English
There will be no trading in the company's shares on July 25, 2024, which is the record date for the capital consolidation Regulatory Filings	2024-07-23	Hebrew (modern)
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split ,The Company’s Shares will begin trading on Nasdaq on July 25, 2024, and on TASE on July 28, 2024 Share Issue/Capital Change	2024-07-23	English
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split ,The Company’s Shares will begin trading on Nasdaq on July 25, 2024, and on TASE on July 28, 2024 Report Publication Announcement	2024-07-23	English
Correction to the identity of filer of the report about Lavie Bio dated July 17, 2024 Regulatory Filings	2024-07-23	English
Correction to the identity of filer of the report about Lavie Bio dated July 17, 2024 Report Publication Announcement	2024-07-23	English
6-K Foreign Filer Report	2024-07-23	English
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants Earnings Release H2 2024	2024-07-17	English
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants Report Publication Announcement	2024-07-17	English
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat Regulatory Filings	2024-07-02	English
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat Report Publication Announcement	2024-07-02	English
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country Regulatory Filings	2024-06-25	English
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country Report Publication Announcement	2024-06-25	English
6-K Foreign Filer Report	2024-06-25	English
Change Management Board/Management Information	2024-06-21	English
Change Management Report Publication Announcement	2024-06-21	English
6-K Foreign Filer Report	2024-06-20	English
Results of the Annual General Meeting of the Shareholders held on June 13, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-18	English
Results of the Annual General Meeting of the Shareholders held on June 13, 2024 AGM Information	2024-06-18	English
6-K Foreign Filer Report	2024-06-17	English
Adjournment of Annual General Meeting-Replacement of attachment AGM Information	2024-06-07	English
Adjournment of Annual General Meeting-Replacement of attachment AGM Information	2024-06-07	English
FORM 6-K-NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 13, 2024 AGM Information	2024-06-07	English
FORM 6-K-NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 13, 2024 AGM Information	2024-06-07	English
FORM 6-K-NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 13, 2024 AGM Information	2024-06-07	English
Adjournment of Annual General Meeting Regulatory Filings	2024-06-07	English
Adjournment of Annual General Meeting AGM Information	2024-06-07	English
6-K Foreign Filer Report	2024-06-06	English
Investor Presentation Investor Presentation	2024-05-29	English
Investor Presentation Report Publication Announcement	2024-05-29	English
6-K Foreign Filer Report	2024-05-29	English
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma Regulatory Filings	2024-05-23	English
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma Regulatory Filings	2024-05-23	English
6-K Foreign Filer Report	2024-05-23	English
Evogene Reports First Quarter 2024 Financial Results Interim / Quarterly Report Q1 2024	2024-05-23	English
Evogene Reports First Quarter 2024 Financial Results Report Publication Announcement	2024-05-23	English
6-K Foreign Filer Report	2024-05-23	English
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds Regulatory Filings	2024-05-21	English
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds Report Publication Announcement	2024-05-21	English
schedules First Quarter 2024 Financial Results Release on May 23, 2024,conference call to discuss the results at 9:00 AM EST Report Publication Announcement	2024-05-09	English
schedules First Quarter 2024 Financial Results Release on May 23, 2024,conference call to discuss the results at 9:00 AM EST Report Publication Announcement	2024-05-09	English
Immediate Report of Meeting To Be Held on June 6, 2024, PROXY AGM Information	2024-05-01	English
Immediate Report of Meeting To Be Held on June 6, 2024, PROXY AGM Information	2024-05-01	English
Immediate Report of Meeting To Be Held on June 6, 2024, PROXY AGM Information	2024-05-01	English
6-K Foreign Filer Report	2024-04-30	English
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting Regulatory Filings	2024-04-16	English
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting Report Publication Announcement	2024-04-16	English
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting Regulatory Filings	2024-04-11	English
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting Report Publication Announcement	2024-04-11	English
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry Regulatory Filings	2024-04-02	English
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry Report Publication Announcement	2024-04-02	English
6-K Foreign Filer Report	2024-04-02	English
Regulatory Filings 2024 Regulatory Filings	2024-03-29	English
FORM 6-K- Sales Agreement with Lake Street Capital Markets Regulatory Filings	2024-03-29	English
FORM 6-K- Sales Agreement with Lake Street Capital Markets Regulatory Filings	2024-03-29	English
Prospectus Supplement date March 28, 2024 Share Issue/Capital Change	2024-03-28	English
Prospectus Supplement date March 28, 2024 Capital/Financing Update	2024-03-28	English
424B5 Prospectus	2024-03-28	English
6-K Foreign Filer Report	2024-03-28	English
20F FOR 2023 Annual Report FY 2023	2024-03-28	English
20F FOR 2023 Report Publication Announcement	2024-03-28	English
20-F Annual Report FY 2023	2024-03-28	English
Regulatory Filings 2024 Regulatory Filings	2024-03-26	English
FORM 6-K Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification Regulatory Filings	2024-03-20	English
FORM 6-K Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification Report Publication Announcement	2024-03-20	English
6-K Foreign Filer Report	2024-03-20	English
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing Regulatory Filings	2024-03-19	English
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing Report Publication Announcement	2024-03-19	English
Regulatory Filings 2024 Regulatory Filings	2024-03-13	English
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America Regulatory Filings	2024-03-13	English
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America Report Publication Announcement	2024-03-13	English
Fourth Quarter and Full Year 2023 Financial Results Regulatory Filings FY 2023	2024-03-07	English
Fourth Quarter and Full Year 2023 Financial Results Report Publication Announcement	2024-03-07	English
6-K Foreign Filer Report	2024-03-07	English
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides Regulatory Filings	2024-03-06	English
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides Report Publication Announcement	2024-03-06	English
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties Regulatory Filings	2024-03-05	English
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties Report Publication Announcement	2024-03-05	English
FORM S-3, PROSPECTUS $200,000,000 of Ordinary Shares, Warrants, Rights and/or Units Offered Capital/Financing Update	2024-03-01	English
FORM S-3, PROSPECTUS $200,000,000 of Ordinary Shares, Warrants, Rights and/or Units Offered Report Publication Announcement	2024-03-01	English
F-3 Regulatory Filings	2024-03-01	English
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements Regulatory Filings	2024-02-28	English
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements Regulatory Filings	2024-02-28	English
Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024,Conference call scheduled for 9:00 AM ET Report Publication Announcement	2024-02-26	English
Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024,Conference call scheduled for 9:00 AM ET Report Publication Announcement	2024-02-26	English
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer Board/Management Information	2024-02-22	English
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer Report Publication Announcement	2024-02-22	English
6-K Foreign Filer Report	2024-02-22	English
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution Regulatory Filings	2024-02-21	English
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution Report Publication Announcement	2024-02-21	English
6-K Foreign Filer Report	2024-02-21	English
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide Regulatory Filings	2024-02-20	English
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide Report Publication Announcement	2024-02-20	English
SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Major Shareholding Notification	2024-02-15	English
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation Regulatory Filings	2024-02-06	English
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation Report Publication Announcement	2024-02-06	English
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit Regulatory Filings	2024-01-23	English
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit Report Publication Announcement	2024-01-23	English
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug Regulatory Filings	2024-01-17	English
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug Report Publication Announcement	2024-01-17	English
6-K Foreign Filer Report	2024-01-17	English
Investor Presentation Investor Presentation	2024-01-09	English
Investor Presentation Report Publication Announcement	2024-01-09	English
6-K Foreign Filer Report	2024-01-09	English

Filings by year

2026 71 filings
2025 95 filings
2024 175 filings
2023 144 filings
2022 164 filings
2021 148 filings
2020 146 filings
2019 105 filings
2018 104 filings
2017 82 filings
2016 118 filings
2015 110 filings
2014 103 filings
2013 33 filings